Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dex2 Vaccine in Advanced Non-Small Cell Lung Cancer
NCT01159288Phase 2Completed
- Sponsor
- Gustave Roussy
- Start
- May 2010
- Primary completion
- Dec 2015
- Modality
- Lipid-based Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Dex2 in non-small cell lung cancer (NSCLC), sponsored by Gustave Roussy. Started May 2010; status: completed.
02
Drugs
Dex2
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01159288.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159288.